You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 19, 2025

Bulk Pharmaceutical API Sources for VICKS FORMULA 44


✉ Email this page to a colleague

« Back to Dashboard


Bulk Pharmaceutical API Sources for VICKS FORMULA 44

Vendor Vendor Homepage Vendor Sku API Url
ChemBridge ⤷  Get Started Free 6699980 ⤷  Get Started Free
Sigma-Aldrich ⤷  Get Started Free D3630_SIGMA ⤷  Get Started Free
Sigma-Aldrich ⤷  Get Started Free D7774_SIGMA ⤷  Get Started Free
TCI (Tokyo Chemical Industry) ⤷  Get Started Free D0423 ⤷  Get Started Free
Molport ⤷  Get Started Free MolPort-000-837-708 ⤷  Get Started Free
Hangzhou APIChem Technology ⤷  Get Started Free AC-3449 ⤷  Get Started Free
AKos Consulting & Solutions ⤷  Get Started Free AKOS005287308 ⤷  Get Started Free
>Vendor >Vendor Homepage >Vendor Sku >API Url

Bulk Active Pharmaceutical Ingredient (API) Sources for VICKS FORMULA 44

Last updated: August 1, 2025

Introduction

VICKS FORMULA 44 is a widely used over-the-counter medication formulated primarily to relieve persistent coughs and congestion associated with colds. Its efficacy relies heavily on its active pharmaceutical ingredient (API). Ensuring reliable, high-quality bulk APIs is crucial for manufacturers and stakeholders within the pharmaceutical supply chain. This report provides a comprehensive overview of potential API sources for VICKS FORMULA 44, examining key API suppliers, industry standards, regulatory considerations, and strategic sourcing insights.

Understanding the API Composition of VICKS FORMULA 44

VICKS FORMULA 44 primarily contains Dextromethorphan Hydrobromide, a cough suppressant, and Guaifenesin, an expectorant, combined with other excipients. For the scope of this analysis, focus will be predominantly on Dextromethorphan Hydrobromide and Guaifenesin, as they are primary APIs responsible for therapeutic efficacy.

Dextromethorphan Hydrobromide

  • Pharmacological Role: Suppresses cough reflex at the brainstem level.
  • Chemical Name: (±)-3-Methoxy-N-methylmorphinan
  • Common Usage: Central cough suppressant.
  • Supply Landscape: Global manufacturers, regulatory pressures, and supply chain issues impact sourcing strategies.

Guaifenesin

  • Pharmacological Role: Facilitates clearance of mucus from the airways.
  • Chemical Name: 3-(2-Methoxyphenoxy)propane-1,2-diol
  • Supply Landscape: Well-established with multiple global suppliers.

Global API Suppliers for VICKS FORMULA 44

1. Major API Manufacturing Regions

  • China: Leading producer of bulk APIs, including Dextromethorphan Hydrobromide and Guaifenesin, owing to cost advantages, significant manufacturing infrastructure, and export capacity.
  • India: Known for high-quality pharmaceutical manufacturing, compliance with international standards (e.g., WHO-GMP, USFDA), and a substantial API export sector.
  • Europe & North America: Smaller but strategically significant suppliers, particularly for specialty or high-purity APIs.

2. Prominent API Manufacturers

a. Dextromethorphan Hydrobromide Suppliers

  • Xinhua Pharmaceutical (China): Produces Dextromethorphan Hydrobromide in accordance with GMP standards. Their capacity supports large-scale supply.
  • Hubei Huidao Pharmaceutical (China): Offers APIs including Dextromethorphan Hydrobromide, with proven export track records.
  • Sun Pharmaceutical Industries Ltd (India): Supplies high-quality Dextromethorphan Hydrobromide, compatible with international quality requirements.
  • Macleods Pharmaceuticals (India): Offers a broad API portfolio, including opioids and non-opioid cough suppressants.

b. Guaifenesin Suppliers

  • Shandong Xinhua Pharmaceutical (China): One of the largest Guaifenesin producers globally.
  • Hetero Labs Limited (India): Known for Guaifenesin production, adhering to international quality standards.
  • Tianjin Drug Research Institute (China): Supplies pharmaceutical grade Guaifenesin.
  • Zhejiang Wuzhou Pharmaceutical (China): Offers APIs aligned with GMP requirements.

3. Contract Manufacturing and API Contract Research Organizations (CROs)

  • Patheon (USA/Europe): Offers contract manufacturing for APIs, including cough suppressants and expectorants.
  • Boehringer Ingelheim (Germany): Provides high-quality APIs for international markets.
  • LGM Pharma (USA): Specializes in sourcing and distributing APIs globally.

Regulatory and Quality Considerations

  • GMP Compliance: Suppliers must adhere to Good Manufacturing Practices, especially for APIs used in OTC products like VICKS FORMULA 44.
  • Certifications: USFDA, EMA, WHO-GMP, and other regional certifications serve as quality assurance indicators.
  • Traceability & Transparency: Suppliers offering detailed Certificates of Analysis (CoA), manufacturing batch records, and strict quality control are preferred.
  • Supply Chain Security: Addressing potential geopolitical or logistical disruptions is critical for continuous API procurement.

Sourcing Strategies for VICKS FORMULA 44 APIs

1. Diversification of API Suppliers

To mitigate supply chain risks, it is advisable to engage multiple suppliers across different regions, balancing cost, quality, and reliability.

2. Regulatory Compatibility

Ensure suppliers possess requisite certifications for markets targeted, such as USFDA approval for North America or EMA approval for Europe.

3. Certification & Quality Assurance

Select suppliers that provide comprehensive documentation, including stability data, GMP compliance certificates, and batch testing reports.

4. Strategic Partnerships

Establish long-term relationships with reputable suppliers, including contractual agreements that specify quality benchmarks, pricing, and delivery timelines.

5. Cost Optimization

Leverage bulk purchasing and negotiate on quality premiums to attain optimal cost-effectiveness.

Emerging Trends and Considerations

a. Clean Label and API Purity

Increasing regulatory and consumer demands for high-purity APIs necessitate sourcing from suppliers that meet stringent purity standards, including residual solvent limits and impurity profiles.

b. Sustainability and Ethical Sourcing

Environmental impact, compliance with local environmental regulations, and ethical labor practices influence supplier selection and strategic sourcing decisions.

c. Digital Traceability

Adoption of digital platforms for API batch tracking and supply chain transparency enhances quality control and responsiveness.

Conclusion

Sourcing bulk APIs for VICKS FORMULA 44 requires a strategic approach emphasizing regulatory compliance, quality assurance, supply reliability, and cost efficiency. Leading suppliers predominantly operate across China and India, with several established pharmaceutical companies offering high-quality APIs aligned with international standards. Engaging diversified sources and leveraging technological advancements in supply chain transparency will support consistent product quality and manufacturing stability.


Key Takeaways

  • Major API sources for VICKS FORMULA 44 include Chinese and Indian manufacturers, notably Xinhua Pharmaceutical, Hubei Huidao, and Hetero Labs.
  • Ensuring GMP compliance and certification is essential for APIs used in OTC formulations.
  • Diversification of API suppliers mitigates risks associated with geopolitical shifts, logistical delays, or quality issues.
  • Advances in digital traceability and sustainability practices increasingly influence sourcing decisions.
  • Long-term partnerships, thorough due diligence, and quality control are vital for maintaining uninterrupted manufacturing of VICKS FORMULA 44.

Frequently Asked Questions (FAQs)

1. What are the primary concerns when sourcing APIs for OTC cough medicines like VICKS FORMULA 44?
Manufacturers must prioritize API purity, GMP compliance, consistent supply, and regulatory approvals to meet safety standards and maintain product efficacy.

2. How do geopolitical factors influence API sourcing for VICKS FORMULA 44?
Trade policies, tariffs, and regional conflicts can impact supply chain stability, prompting companies to diversify sources across multiple regions.

3. Are Chinese API manufacturers suitable for producing APIs for international OTC markets?
Yes, many Chinese suppliers maintain GMP standards and international certifications suitable for export, but due diligence and verification are crucial.

4. What role does regulatory certification play in API selection?
Regulatory certifications like USFDA or EMA approval guarantee adherence to quality standards, reducing compliance risks in the final product.

5. How can companies ensure the traceability and quality of imported APIs?
Request detailed Certificates of Analysis, batch records, supplier audits, and implement digital monitoring systems for real-time supply chain visibility.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.